These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 16951005)

  • 61. Outcomes of primary liver cancer in children: an appraisal of experience.
    Pham TH; Iqbal CW; Grams JM; Zarroug AE; Wall JC; Ishitani MB; Nagorney DM; Moir C
    J Pediatr Surg; 2007 May; 42(5):834-9. PubMed ID: 17502194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
    Kim JH; Moon H; Noh J; Lee J; Kim SG
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Paragangliomas: clinical overview.
    Young WF
    Ann N Y Acad Sci; 2006 Aug; 1073():21-9. PubMed ID: 17102068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Incidence of pheochromocytoma in trauma patients during the management of unrelated illness: a retrospective review.
    Kirshtein B; Pagliarello G; Yelle JD; Poulin EC
    Int J Surg; 2007 Oct; 5(5):332-5. PubMed ID: 17561462
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.
    Forrer F; Riedweg I; Maecke HR; Mueller-Brand J
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):334-40. PubMed ID: 18480742
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.
    Kinney MA; Warner ME; vanHeerden JA; Horlocker TT; Young WF; Schroeder DR; Maxson PM; Warner MA
    Anesth Analg; 2000 Nov; 91(5):1118-23. PubMed ID: 11049893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pheochromocytoma: current approaches and future directions.
    Adler JT; Meyer-Rochow GY; Chen H; Benn DE; Robinson BG; Sippel RS; Sidhu SB
    Oncologist; 2008 Jul; 13(7):779-93. PubMed ID: 18617683
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Surgical experiences with adrenal tumors (author's transl)].
    Rubay J; Mousset G; Guiot P
    Acta Chir Belg; 1980; 79(6):415-22. PubMed ID: 7245996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic testing in pheochromocytoma: increasing importance for clinical decision making.
    Bornstein SR; Gimenez-Roqueplo AP
    Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pheochromocytoma crisis is not a surgical emergency.
    Scholten A; Cisco RM; Vriens MR; Cohen JK; Mitmaker EJ; Liu C; Tyrrell JB; Shen WT; Duh QY
    J Clin Endocrinol Metab; 2013 Feb; 98(2):581-91. PubMed ID: 23284003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pheochromocytoma and paraganglioma].
    Gimenez-Roqueplo AP
    Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of paragangliomas in otolaryngology practice: review of a 7-year experience.
    Karaman E; Isildak H; Yilmaz M; Edizer DT; Ibrahimov M; Cansiz H; Korkut N; Enver O
    J Craniofac Surg; 2009 Jul; 20(4):1294-7. PubMed ID: 19625854
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The genetic basis of pheochromocytoma and paraganglioma: implications for management.
    Shuch B; Ricketts CJ; Metwalli AR; Pacak K; Linehan WM
    Urology; 2014 Jun; 83(6):1225-32. PubMed ID: 24642075
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Retroperitoneal laparoscopic resection for pheochromocytoma (experience of 107 cases)].
    Li HZ; Yan WG; Zeng ZP; Huang YG
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(24):1875-8. PubMed ID: 19134374
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.
    Lowery AJ; Walsh S; McDermott EW; Prichard RS
    Oncologist; 2013; 18(4):391-407. PubMed ID: 23576482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the "subclinical" pheochromocytoma.
    Lee JA; Zarnegar R; Shen WT; Kebebew E; Clark OH; Duh QY
    Arch Surg; 2007 Sep; 142(9):870-3; discussion 73-4. PubMed ID: 17875842
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phaeochromocytoma, new genes and screening strategies.
    Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center.
    Asban A; Kluijfhout WP; Drake FT; Beninato T; Wang E; Chomsky-Higgins K; Shen WT; Gosnell JE; Suh I; Duh QY
    J Surg Oncol; 2018 May; 117(6):1217-1222. PubMed ID: 29315604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical spectrum and outcome of functional extraadrenal paraganglioma.
    O'Riordain DS; Young WF; Grant CS; Carney JA; van Heerden JA
    World J Surg; 1996 Sep; 20(7):916-21; discussion 922. PubMed ID: 8678971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA flow cytometry in pheochromocytoma and paraganglioma.
    Jung WH; Yang WI; Park C; Choi IJ
    Yonsei Med J; 1992 Sep; 33(3):249-57. PubMed ID: 1292249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.